1217 related articles for article (PubMed ID: 27531851)
21. Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.
Metcalf RA; Khan J; Andrews J; Mayock D; Billimoria Z; Pagano MB
J Pediatr Hematol Oncol; 2019 Nov; 41(8):632-634. PubMed ID: 30044350
[TBL] [Abstract][Full Text] [Related]
22. Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates.
Herschel M; Karrison T; Wen M; Caldarelli L; Baron B
Pediatrics; 2002 Jul; 110(1 Pt 1):127-30. PubMed ID: 12093957
[TBL] [Abstract][Full Text] [Related]
23. Significance of immunohematologic testing in mother and newborn ABO incompatibility.
Novoselac J; Buzina Marić K; Rimac V; Selak I; Raos M; Golubić Ćepulić B
Immunohematology; 2023 Jun; 39(2):55-60. PubMed ID: 37405847
[TBL] [Abstract][Full Text] [Related]
24. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
25. Neonatal BO Incompatibility Is Associated With a Positive Cord Blood Direct Antiglobulin Test in Infants of Black Ethnicity.
Özgönenel B; Kukreja G; O'Malley B; Bluth MH
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e453-7. PubMed ID: 26422285
[TBL] [Abstract][Full Text] [Related]
26. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
27. Neonatal hemolytic disease: How should we use indirect and direct antiglobulin tests?
Sevuk Ozumut SH; Turhan AB
Pediatr Neonatol; 2024 Jan; 65(1):11-16. PubMed ID: 37414722
[TBL] [Abstract][Full Text] [Related]
28. Neonatal jaundice due to ABO incompatibility in Sri Lankan.
Lucas GN
Indian J Pediatr; 1996; 63(3):381-4. PubMed ID: 10830015
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
30. Hemolytic Disease of the Fetus and Newborn Caused by Anti-Group A IgG From a Group B Mother.
Wang R; Li Y; Tong Y; Su N
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e785-e787. PubMed ID: 33003144
[TBL] [Abstract][Full Text] [Related]
31. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
32. [Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn].
Cianciarullo MA; Ceccon ME; Vaz Fv
Rev Assoc Med Bras (1992); 2003; 49(1):45-53. PubMed ID: 12724812
[TBL] [Abstract][Full Text] [Related]
33. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
Whyte J; Graham H
Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
[TBL] [Abstract][Full Text] [Related]
34. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
35. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
36. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of a solid-phase test for red cell antibody screening of pregnant women.
Shanwell A; Sallander S; Bremme K; Westgren M
Transfusion; 1999 Jan; 39(1):26-31. PubMed ID: 9920163
[TBL] [Abstract][Full Text] [Related]
38. Neonatal screening of ABO/RhD blood group and direct antiglobulin Coombs test. Experience of a single institution.
Baptista-González HA; Rodríguez-Alvarado AG; Bouchán-Valencia P; Coeto-Barona G; Coronado-Zarco IA
Bol Med Hosp Infant Mex; 2024; 81(2):97-105. PubMed ID: 38768512
[TBL] [Abstract][Full Text] [Related]
39. Post-test probability for neonatal hyperbilirubinemia based on umbilical cord blood bilirubin, direct antiglobulin test, and ABO compatibility results.
Peeters B; Geerts I; Van Mullem M; Micalessi I; Saegeman V; Moerman J
Eur J Pediatr; 2016 May; 175(5):651-7. PubMed ID: 26782094
[TBL] [Abstract][Full Text] [Related]
40. [Severe hemolytic disease of the newborn as a result of late and undiagnosed alloimmunization--case report].
Drozdowska-Szymczak A; Czaplińska N; Borek-Dziecioł B; Kociszewska-Najman B; Bartkowiak R; Wielgoś M
Ginekol Pol; 2014 Mar; 85(3):226-9. PubMed ID: 24783436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
